Neurografix v. Brainlab Inc

I. Executive Summary and Procedural Information

• Parties & Counsel:
  • Plaintiff: NeuroGrafix et al. (California)
  • Defendant: Brainlab, Inc. et al. (Delaware, Germany)
  • Plaintiff's Counsel: Russ August & Kabat; McDonnell Boehnen Hulbert & Berghoff LLP
• Case Identification: 1:13-cv-10758, D. Mass., 04/28/2014
• Venue Allegations: Venue is alleged based on Defendants advertising, marketing, using, selling, or offering to sell products within the judicial district. The case was transferred to the District of Massachusetts for pretrial purposes.
• Core Dispute: Plaintiffs allege that Defendant's medical imaging software and systems infringe a patent related to methods for generating images of nerve tissue using magnetic resonance imaging (MRI).
• Technical Context: The technology at issue involves advanced MRI techniques, specifically diffusion tensor imaging (DTI), to visualize nerve fiber pathways (tractography), a capability significant for neurosurgical planning and the diagnosis of neural disorders.
• Key Procedural History: The complaint alleges that Defendants were on notice of the patent-in-suit as early as May 2009, when an inventor and plaintiff, Dr. Filler, contacted them to discuss a potential license. The patent has a complex ownership and licensing history, originating with the University of Washington and involving multiple assignments and exclusive license agreements.

Case Timeline

II. Technology and Patent(s)-in-Suit Analysis

U.S. Patent No. 5,560,360 - "Image Neurography and Diffusion Anisotropy Imaging"

• Patent Identification: U.S. Patent No. 5,560,360, issued October 1, 1996 (the "'360 Patent").

The Invention Explained

• Problem Addressed: The patent's background section states that prior to the invention, there was no successful method for imaging peripheral, autonomic, and cranial nerves using techniques like MRI ʼ360 Patent, col. 1:28-32 These nerves are difficult to locate and identify due to their small size and close proximity to other tissues of similar appearance ʼ360 Patent, col. 1:35-38
• The Patented Solution: The invention discloses a method and system for generating clear, three-dimensional images of nerve tissue non-invasively using a modified MRI process ʼ360 Patent, col. 6:11-15 The method exploits the unique property of "anisotropic diffusion" in nerve tissue-the tendency for water to diffuse more freely along the length of a nerve fiber than across it ʼ360 Patent, col. 6:58-63 By applying specific magnetic field gradients ("diffusion weighting") and processing the resulting signals, the system can distinguish nerve tissue from surrounding isotropic tissues like fat and muscle ʼ360 Patent, abstract The solution also incorporates techniques like fat suppression to further enhance the visibility, or "conspicuity," of the nerves in the final image ʼ360 Patent, col. 9:1-10
• Technical Importance: This technology provided a method to non-invasively visualize nerve networks with a level of detail previously unavailable, which could enhance the diagnosis of neural trauma and inform surgical planning ʼ360 Patent, col. 6:7-10

Key Claims at a Glance

• The complaint asserts independent claim 36 Compl. ¶23
• The essential elements of claim 36 are:
  • Exposing a region containing a structure that exhibits diffusion anisotropy (e.g., a nerve) to a magnetic polarizing field that includes a "predetermined arrangement of diffusion-weighted gradients."
  • Exposing the region to an electromagnetic excitation field.
  • Sensing a resonant response for each of the diffusion-weighted gradients and producing a corresponding output.
  • Performing "vector processing" on the outputs to generate data representing the anisotropic diffusion.
  • Processing this anisotropic diffusion data to generate a final data set that describes the shape and position of the structure, distinguishing it from other structures that do not exhibit diffusion anisotropy.

III. The Accused Instrumentality

Product Identification

The accused products include "Defendants' Brainsuite iMRI and related software, such as iPlan Fibertracking software," as well as "BOLD MRI Mapping software, iPlan RT, iPlan Flow, iPlan Neuroradiology, and courses taught at the Defendants' Academy" Compl. ¶23 Compl. ¶24

Functionality and Market Context

The complaint alleges these products and services are for "DTI and diffusion anisotropy based tractography" Compl. ¶23 This functionality involves processing MRI data to map the pathways of nerve fibers in the brain and other parts of the body Compl. ¶23 The complaint states these products are used by direct infringers such as hospitals and radiologists in the United States Compl. ¶24

IV. Analysis of Infringement Allegations

No probative visual evidence provided in complaint.

'360 Patent Infringement Allegations

Identified Points of Contention

• Scope Questions: A central dispute may concern the scope of the term "vector processing." The question for the court will be whether the specific algorithms used in Defendants' software for calculating nerve fiber orientation and pathways fall within the meaning of "vector processing" as defined by the patent's claims and specification.
• Technical Questions: The complaint makes a high-level allegation that the accused products perform "tractography." What evidence does the complaint provide that the accused software's method for generating these tractography images meets every limitation of the claimed method? The analysis will likely focus on whether the software generates an intermediate "data representative of anisotropic diffusion" which is then separately processed to create the final "data set describing the shape and position," as the claim structure suggests.

V. Key Claim Terms for Construction

• The Term: "vector processing"

  • Context and Importance: This term describes the core computational step for converting raw MRI signals into directional diffusion data. The outcome of the infringement analysis may depend heavily on whether this term is construed broadly to cover any algorithm that determines diffusion directionality, or narrowly to cover only specific mathematical methods disclosed in the patent.
  • Intrinsic Evidence for Interpretation:
    • Evidence for a Broader Interpretation: The claim uses the general term "vector processing" without specifying a particular formula, which may support an interpretation that covers any process that treats the diffusion data as a vector quantity to determine its properties.
    • Evidence for a Narrower Interpretation: The specification discloses a specific method for calculating a "diffusion vector" and its "vector length" using a particular equation '360 Patent, col. 20:30-54 Defendants may argue this disclosure limits the scope of "vector processing" to this or technically similar implementations.

• The Term: "a data set describing the shape and position of said selected structure"

  • Context and Importance: This term defines the final output of the claimed method. The nature of the files or images generated by the accused software will be compared to the court's construction of this term. A key question is what level of processing and what format of data constitutes this claimed "data set."
  • Intrinsic Evidence for Interpretation:
    • Evidence for a Broader Interpretation: The term "data set" is general and could be interpreted to mean any collection of digital information-from raw voxel data to a final rendered image file-from which the structure's shape and position can be ascertained.
    • Evidence for a Narrower Interpretation: The specification repeatedly discusses producing two- and three-dimensional images and projections, which could be used to argue that the "data set" must be a processed, visually representable file format rather than an intermediate or raw data structure '360 Patent, col. 19:28-46

VI. Other Allegations

• Indirect Infringement: The complaint alleges both induced and contributory infringement. Inducement is based on allegations that Defendants encourage customers like hospitals and radiologists to perform the claimed method through marketing materials and training courses Compl. ¶24 Contributory infringement is based on the allegation that the accused software is a material part of the invention, is specially adapted for performing DTI tractography, and is not a staple article of commerce with substantial non-infringing uses Compl. ¶25
• Willful Infringement: The willfulness allegation is based on alleged pre-suit knowledge of the '360 Patent. The complaint states that an inventor, Dr. Filler, sent an email to Defendants in May 2009 "informing them that they infringe the '360 Patent" and offering to discuss a license Compl. ¶21 Compl. ¶26

VII. Analyst's Conclusion: Key Questions for the Case

• A core issue will be one of definitional scope: can the term "vector processing," as described in the patent, be construed to cover the specific computational algorithms implemented in Defendants' Brainsuite iMRI and iPlan Fibertracking software? The resolution will depend on whether the court finds the term is limited by the specific equations in the specification or encompasses a broader class of directional data analysis techniques.
• A second key issue will be one of evidentiary proof: given the complaint's generalized allegations, the case may turn on Plaintiffs' ability to produce technical evidence demonstrating, on an element-by-element basis, that the accused software's internal operations map directly onto the specific sequence of steps recited in claim 36. This will require a detailed factual analysis of the software's architecture and data flow.